Literature DB >> 24131636

Molecular targets for antifibrotic therapy in liver disease: using magic bullets for crossfire rather than a one-sided shotgun attack.

Claus Hellerbrand.   

Abstract

Entities:  

Keywords:  Hepatic Fibrosis; Hepatic Stellate Cell

Mesh：

Substances：

Year:  2013        PMID： 24131636     DOI： 10.1136/gutjnl-2013-305908

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  5 in total

1.  Increased expression of c-Jun in nonalcoholic fatty liver disease.

Authors:  Christoph Dorn; Julia C Engelmann; Michael Saugspier; Andreas Koch; Arndt Hartmann; Martina Müller; Rainer Spang; Anja Bosserhoff; Claus Hellerbrand
Journal:  Lab Invest       Date:  2014-02-03       Impact factor: 5.662

2.  Adenoviral‑bone morphogenetic protein‑7 and/or doxazosin therapies promote the reversion of fibrosis/cirrhosis in a cirrhotic hamster model.

Authors:  Daniel Cervantes-Garcia; Adriana Guadalupe Cuellar-Juarez; Gissela Borrego-Soto; Augusto Rojas-Martinez; Liseth Rubi Aldaba-Muruato; Eva Salinas; Javier Ventura-Juarez; Martin Humberto Muñoz-Ortega
Journal:  Mol Med Rep       Date:  2017-10-12       Impact factor: 2.952

3.  Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway.

Authors:  Li Xuanfei; Chen Hao; Yi Zhujun; Liu Yanming; Gong Jianping
Journal:  Oncotarget       Date:  2017-03-28

4.  Riboflavin ameliorates mitochondrial dysfunction via the AMPK/PGC1α/HO‑1 signaling pathway and attenuates carbon tetrachloride‑induced liver fibrosis in rats.

Authors:  Ning Tang; Feng Hong; Wei Hao; Ting-Ting Yu; Guo-Guang Wang; Wei Li
Journal:  Exp Ther Med       Date:  2022-08-02       Impact factor: 2.751

5.  Doxazosin Treatment Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Hamsters through a Decrease in Transforming Growth Factor β Secretion.

Authors:  Martin Humberto Muñoz-Ortega; Raúl Wiliberto Llamas-Ramírez; Norma Isabel Romero-Delgadillo; Tania Guadalupe Elías-Flores; Edgar de Jesus Tavares-Rodríguez; María Del Rosario Campos-Esparza; Daniel Cervantes-García; Luis Muñoz-Fernández; Martin Gerardo-Rodríguez; Javier Ventura-Juárez
Journal:  Gut Liver       Date:  2016-01       Impact factor: 4.519
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.